Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
Headache: The Journal of Head and Face Pain · 2025
DOI: 10.1111/head.14974 ↗At a glance
Journal article in Headache: The Journal of Head and Face Pain, 2025. Written by Richard B Lipton and 5 co-authors. Institution: Department of Neurology, Albert Einstein College, Bronx, New York, USA. Major MEDLINE topics: Migraine Disorders, Patient Preference, Choice Behavior, Calcitonin Gene-Related Peptide Receptor Antagonists. Cited 6 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: AbbVie, Inc.
Abstract (original language)
Objectives
This study was conducted among participants with episodic migraine, to (i) assess patient preferences for attributes associated with calcitonin gene‐related peptide‐targeting therapies to prevent migraine and (ii) predict the probability that a real‐world patient would prefer an atogepant‐like treatment profile over monoclonal antibody‐like profiles.
Background
Calcitonin gene‐related peptide‐targeting therapies have emerged as safe and effective first‐line preventive treatments for migraine. Given the expansion of the treatment landscape, it is important to understand what drives treatment choices among patients with migraine. However, few studies have quantified patient preferences for attributes of preventive treatments for migraine.
Methods
A discrete‐choice experiment survey was administered to adults (aged 18–80 years and
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurology, Albert Einstein College, Bronx, New York, USA.
- Health Economics and Outcomes Research, AbbVie, Inc., Chicago, Illinois, USA.
- Health Preference Assessment, RTI Health Solutions, Research Triangle Park, North Carolina, USA.
- Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID profiles: Richard B Lipton
Funding
- AbbVie, Inc
Cite
APA
Lipton, R. B., Gandhi, P., Myers, K., Bussberg, C., Stokes, J., & Nahas, S. J. (2025). Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14974
Vancouver
Lipton RB, Gandhi P, Myers K, Bussberg C, Stokes J, Nahas SJ. Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment. Headache: The Journal of Head and Face Pain. 2025. doi:10.1111/head.14974
BibTeX
@article{Lipton2025,
author = {Lipton, Richard B and Gandhi, Pranav and Myers, Kelley and Bussberg, Cooper and Stokes, Jonathan and Nahas, Stephanie J},
title = {Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment},
journal = {Headache: The Journal of Head and Face Pain},
year = {2025},
doi = {10.1111/head.14974}
}
EUVIMED